Source link : https://www.newshealth.biz/health-news/fda-could-soon-limit-use-of-only-drug-for-covid-prevention/
Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday. The agency revised the emergency use authorization (EUA) for the long-acting monoclonal antibody based […]
Author : News Health
Publish date : 2024-08-27 15:33:43
Copyright for syndicated content belongs to the linked Source.
Categories